Sonde Health announces it has been selected by AFWERX for a SBIR Phase II contract in the amount of $1,215,606 focused on Sonde Mental Fitness to address the most pressing challenges in the Department of the Air Force (DAF).

Burnout is difficult to detect, and the best recourse is taking preemptive action before you hit the wall. Now, a new and non-invasive technology from Sonde Health helps detect signs of burnout through your voice.

Sonde’s vocal biomarker can either pick up on a user's voice passively, so long as the app is open on a phone, or actively with a 30-second audio message once a day.

Non-invasive health detection and monitoring technology analyzes vocal biomarkers to indicate a user's ongoing cognitive efficiency

Sonde Health and KT Corporation (KT) have agreed to collaborate on a next-generation mental health management solution.

Discover how Sonde is helping digital health firms enact behavioral change in the fight against chronic disease.

Learn how Sonde Health's vocal biomarker technology enhances frontline worker productivity by proactively monitoring stress and mental wellbeing in a non-invasive, cost-effective way.

We are pleased to announce that a new study has validated the effectiveness of our Mental Fitness Vocal Biomarker (MFVB) and the research has been published in the peer-reviewed journal, Frontiers in Psychiatry. Our latest study has demonstrated the remarkable capability of our MFVB platform to accurately discern individuals' mental health symptoms based on short recordings of their voice. 

Our new study published in Frontiers in Psychiatry points to mental fitness vocal biomarkers (MFVB) as a promising approach to support mental health monitoring, engagement, and care.

Leading enterprise vocal biomarker company Sonde Health has been selected by AFWERX for a Phase I Small Business Innovation Research (SBIR) award in the amount of $71,166, focused on utilizing Sonde Mental Fitness to address the most pressing challenges in the Department of the Air Force (DAF).

Leading enterprise vocal biomarker company Sonde Health has partnered with Together, an AI-based health assistant, to provide enhanced mental health detection and monitoring through its new Mental Vitals feature. This collaboration integrates Sonde’s pioneering technology into the Together app, allowing users to access advanced voice analysis for early detection of symptoms related to depression and anxiety. Launched only a month ago, more than 20% of Together’s daily users are already using Sonde-powered Mental Vitals.

BOSTON, MA — May 23, 2023 — Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, has revealed new research that demonstrates the ability of its respiratory responsive vocal biomarker (RRVB) machine learning model to differentiate patients with COVID-19 from healthy individuals with about 70% accuracy.

Hidden away in our voices are signals that may hold clues to how we’re doing, what we’re feeling and even what’s going on with our physical health. Now, AI systems tasked with analyzing these signals are moving into healthcare.

Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, in conjunction with the Massachusetts General Hospital (MGH) Frontotemporal Disorders (FTD) Unit, has been selected by the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC) to lead a pilot study focused on leveraging vocal biomarkers for remote detection and monitoring of mild cognitive impairment in the home environment.

By David Liu, CEO Sonde Health December 8th, 2022

I am beyond excited to share the latest major milestone in Sonde’s journey to making preventive care possible through voice-powered health monitoring.

We have raised $19.25 million in Series B funding, led by Partners Investment, with NEOM Company and KT Corporation participating. Our existing investors, co-founder PureTech Health, M Ventures, MP Healthcare Venture Management, Neoteny and Evidity Health Capital all came back and invested in this round. 

BOSTON – Dec. 8, 2022 – Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, has raised a $19.25 million Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. The company has raised $35.25 million in total and will use the funding to drive its global commercial growth, deepen its respiratory and mental health monitoring technologies, and build capabilities for additional health conditions.

By Elizabeth Svoboda Updated December 8, 2022, 3:00 a.m.

New apps promise to detect when you’re feeling blue and o!er some

assistance. But they still have to prove that the benefits of sharing

sensitive data outweigh any drawbacks.

Sonde Health raised $19.25 million in Series B funding to globalize its voice-based disease screening technology with partners in Korea and India. CEO David Liu tells Axios exclusively.

SEOUL -- South Korea's top telecom company KT will enhance the competitiveness of the artificial intelligence-based health diagnosis business through a strategic investment in Sonde Health, a United States-based digital medicine company specializing in the detection of various diseases such as mental health and respiratory disorders through the analysis of voices.

Software that analyzes snippets of your speech to identify mental health problems is rapidly making its way into call centers, medical clinics and telehealth platforms. The idea is to detect illnesses that might otherwise go untreated. Why it matters: Proponents of "voice biomarker" technology say the underlying artificial intelligence is good enough to recognize depression, anxiety and a host of other maladies.

Sonde Health, a leading enterprise vocal biomarker company, today announced that it has integrated the M3 Checklist into its Mental Fitness application programming interface (API), giving Sonde customers’ users access to a multi-conditional assessment tool that measures symptoms for major depression, bipolar disorder, anxiety disorder, and post-traumatic stress disorder (PTSD).

Sonde Health, a leading enterprise vocal biomarker company, has signed a multi-year agreement with Koye Pharmaceuticals, a specialty pharma organization focused on the Indian Pharmaceutical market, to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India. This deal represents Sonde’s first partnership with a pharmaceutical company.

David Liu is CEO of Sonde Health, a company using vocal biomarkers to assess patient health, wellness, and fitness. The company is white labeling its solution for app developers with initial products for respiratory and mental health problems.

In the interview, Liu discusses the product, technology, and key markets serving as the first adopters. These include healthcare providers and payers along with one industry I wasn’t expecting.

Liu has been CEO of Sonde Health since 2019. He previously was the chief operating officer at Quartet Health and education technology company Knewton and was a senior vice president at AOL. He earned an engineering degree from Purdue and an MBA from Columbia.

Sonde’s vocal biomarker technology to analyze ongoing mental and physical health challenges of people across four African countries during the COVID-19 pandemic

Sonde Health, in collaboration with Michigan State University, University of Botswana, University of Ghana, University of Dar es Salaam, and University of Nigeria, Nsukka, has launched a new study that uses vocal biomarkers to identify and understand the relationship among physical activity, mental health, and respiratory health of individuals living in Africa during the COVID-19 pandemic.

BOSTON--(BUSINESS WIRE)--Sonde Health and the Cognitive Behavior Institute (CBI) have teamed up to study the effectiveness of Sonde’s Mental Fitness app as an engagement and monitoring tool for patients with depression and anxiety to help health systems and wellness service providers enhance patient care.

The study will use Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that analyzes the sound of patients’ voices to evaluate aspects of mental well-being. By combining voice recordings, patient symptoms, and medical data, this research will enable Sonde to continue to improve its vocal biomarker models for depression and mental health monitoring.

A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer's, and other conditions.

Vocal biomarkers can be highly useful, telling caregivers and researchers things that other vital signs are not able to fully show. Outsourcing-Pharma recently spoke with David Liu, CEO of health technology company Sonde Health, about the potential of vocal biomarkers in research and care, and how the company's voice-enabled symptom detection and monitoring platform can be useful in watching chronic and mental health conditions

Remote patient monitoring—using electronic devices to collect and record health and medical data in one location and having that data reviewed by a provider in another location—has become much more mainstream. RPM enables aging patients, individuals with chronic diseases and others to better manage their health remotely.

The Covid-19 pandemic has enhanced the use of RPM technology. But the real boom is still coming.

Imagine a test as quick and easy as having your temperature taken or your blood pressure measured that could reliably identify an anxiety disorder or predict an impending depressive relapse.

Health care providers have many tools to gauge a patient’s physical condition, yet no reliable biomarkers — objective indicators of medical states observed from outside the patient — for assessing mental health.

But some artificial intelligence researchers now believe that the sound of your voice might be the key to understanding your mental state — and A.I. is perfectly suited to detect such changes, which are difficult, if not impossible, to perceive otherwise. The result is a set of apps and online tools designed to track your mental status, as well as programs that deliver real-time mental health assessments to telehealth and call-center providers.